EP3159018A3 - Gradient coating for biomedical applications - Google Patents

Gradient coating for biomedical applications Download PDF

Info

Publication number
EP3159018A3
EP3159018A3 EP16184407.1A EP16184407A EP3159018A3 EP 3159018 A3 EP3159018 A3 EP 3159018A3 EP 16184407 A EP16184407 A EP 16184407A EP 3159018 A3 EP3159018 A3 EP 3159018A3
Authority
EP
European Patent Office
Prior art keywords
biomedical applications
gradient coating
coating
antimicrobial agent
gradient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP16184407.1A
Other languages
German (de)
French (fr)
Other versions
EP3159018A2 (en
EP3159018B1 (en
Inventor
Lu Gan
Marcus L SCOTT
Shilesh C Jani
Laura S WHITSITT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith and Nephew Inc
Original Assignee
Smith and Nephew Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith and Nephew Inc filed Critical Smith and Nephew Inc
Publication of EP3159018A2 publication Critical patent/EP3159018A2/en
Publication of EP3159018A3 publication Critical patent/EP3159018A3/en
Application granted granted Critical
Publication of EP3159018B1 publication Critical patent/EP3159018B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/30—Inorganic materials
    • A61L27/306—Other specific inorganic materials not covered by A61L27/303 - A61L27/32
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/30—Inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104—Silver, e.g. silver sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/112—Phosphorus-containing compounds, e.g. phosphates, phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/408—Virucides, spermicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/06—Coatings containing a mixture of two or more compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/08—Coatings comprising two or more layers

Abstract

The present invention provides a coating comprising a bioactive material and an antimicrobial agent, wherein the concentration of said antimicrobial agent varies throughout the thickness of the coating.
EP16184407.1A 2008-02-29 2009-02-27 Gradient coating for biomedical applications Active EP3159018B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3276708P 2008-02-29 2008-02-29
EP09718375.0A EP2259805B1 (en) 2008-02-29 2009-02-27 Gradient coating for biomedical applications
PCT/US2009/035444 WO2009111300A2 (en) 2008-02-29 2009-02-27 Gradient coating for biomedical applications

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
EP09718375.0A Division EP2259805B1 (en) 2008-02-29 2009-02-27 Gradient coating for biomedical applications

Publications (3)

Publication Number Publication Date
EP3159018A2 EP3159018A2 (en) 2017-04-26
EP3159018A3 true EP3159018A3 (en) 2017-05-10
EP3159018B1 EP3159018B1 (en) 2022-04-20

Family

ID=41056558

Family Applications (2)

Application Number Title Priority Date Filing Date
EP09718375.0A Active EP2259805B1 (en) 2008-02-29 2009-02-27 Gradient coating for biomedical applications
EP16184407.1A Active EP3159018B1 (en) 2008-02-29 2009-02-27 Gradient coating for biomedical applications

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP09718375.0A Active EP2259805B1 (en) 2008-02-29 2009-02-27 Gradient coating for biomedical applications

Country Status (8)

Country Link
US (1) US9011965B2 (en)
EP (2) EP2259805B1 (en)
JP (4) JP2011512957A (en)
CN (2) CN102014975A (en)
AU (2) AU2009222165B2 (en)
CA (1) CA2716896C (en)
ES (1) ES2603961T3 (en)
WO (1) WO2009111300A2 (en)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2022447A1 (en) * 2007-07-09 2009-02-11 Astra Tech AB Nanosurface
CN102014975A (en) 2008-02-29 2011-04-13 史密夫和内修有限公司 Gradient coating for biomedical applications
CN105963781A (en) 2008-02-29 2016-09-28 史密夫和内修有限公司 Coating and coating method
IT1394800B1 (en) * 2009-07-10 2012-07-13 Univ Degli Studi Torino BONE COMPOSITE CEMENTS WITH PMMA MATRIX, CONTAINING BIOACTIVE AND ANTIBACTERIAL GLASSES AND CERAMIC GLASSES
US8275516B2 (en) * 2009-07-21 2012-09-25 Trimble Navigation Limited Agricultural vehicle autopilot rollover risk assessment system
EP2543399A3 (en) * 2009-12-18 2013-07-10 Dentsply IH AB Medical device for short time use with quickly releasable antibacterial agent
JP5878477B2 (en) * 2010-01-15 2016-03-08 ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー Use of vanadium compounds to accelerate bone healing
US9453289B2 (en) * 2010-04-13 2016-09-27 Lawrence Livermore National Security, Llc Methods of three-dimensional electrophoretic deposition for ceramic and cermet applications and systems thereof
CN101797399A (en) * 2010-04-15 2010-08-11 四川大学 Biomedical material with silver-ion-bearing hydroxyapatite coating and preparation method thereof
EP2382960A1 (en) * 2010-04-19 2011-11-02 DERU GmbH Entwicklung von medizinischen Produkten Implant with antimicrobial coating
CN103052410B (en) * 2010-07-09 2015-04-22 欧瑞康贸易股份公司(特吕巴赫) Antibacterial medicinal product and method for producing same
US9852824B2 (en) 2010-08-24 2017-12-26 Lawrence Livermore National Security, Llc Methods for controlling pore morphology in aerogels using electric fields and products thereof
EP2640430B1 (en) * 2010-11-17 2016-03-09 Zimmer, Inc. Ceramic monoblock implants with osseointegration fixation surfaces
WO2013006798A1 (en) 2011-07-06 2013-01-10 University Of Medicine And Dentistry Of New Jersey Vandium compounds as therapeutic adjuncts for cartilage regeneration and repair
US20140322292A1 (en) 2010-12-10 2014-10-30 Rutgers, The State University Of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration
KR20140048076A (en) 2010-12-10 2014-04-23 유니버시티 오브 메디신 앤드 덴티스트리 오브 뉴 저지 Implantable devices coated with insulin-mimetic agent composites and methods thereof
US9440002B2 (en) * 2011-04-01 2016-09-13 Washington State University Materials with modified surfaces and methods of manufacturing
US9290855B2 (en) * 2011-04-22 2016-03-22 Lawrence Livermore National Security, Llc Stabilization of green bodies via sacrificial gelling agent during electrophoretic deposition
EP2529763B1 (en) * 2011-06-03 2016-10-12 Waldemar Link GmbH & Co. KG Method for manufacturing an implant coating and implant
CN102294052B (en) * 2011-07-27 2013-09-25 东南大学 Preparation method of medical high polymer based silver nano material
CA3127015A1 (en) * 2011-11-29 2013-06-06 Rutgers, The State University Of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration
US9649338B2 (en) * 2012-03-02 2017-05-16 Rowan University Use of silver-containing layers at implant surfaces
EP2641621A1 (en) * 2012-03-23 2013-09-25 Elos Medtech Pinol A/S Strontium based coating for body implants
CN103520779B (en) * 2012-07-02 2014-12-24 李亚屏 Porous composite biological material containing multiple active ions and preparation method thereof
CN102776499B (en) * 2012-07-30 2014-04-02 同济大学 Biomimetic mineralization method for preparing magnesium alloy-calcium phosphate coating composite material
US20140114382A1 (en) * 2012-09-10 2014-04-24 Keun-Young Anthony Kim Stimulating bone growth and controlling spinal cord pain
DE102013211175A1 (en) * 2013-06-14 2014-12-18 R + K CAD/CAM Technologie GmbH & Co. KG Production of semi-finished products for implants based on plastic
CN103668397B (en) * 2014-01-07 2016-01-20 景德镇陶瓷学院 A kind of high-activity biological gradient cladding for titanium alloy surface
US11039621B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9622483B2 (en) 2014-02-19 2017-04-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039620B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
EP3122556B1 (en) * 2014-03-26 2020-02-19 Nanovis, LLC Anti-microbial device and method for its manufacture
FR3020759B1 (en) * 2014-05-06 2017-10-13 Rv Finances COATING MATERIAL FOR IMPLANTABLE MEDICAL DEVICE, IMPLANTABLE MEDICAL DEVICE COATED WITH SUCH MATERIAL AND METHOD OF MANUFACTURING THE SAME
US9713655B2 (en) 2014-06-13 2017-07-25 Acuitive Technologies, Inc. Joint replacement or joint resurfacing devices, systems and methods
CN104857563A (en) * 2015-05-25 2015-08-26 苏州奥芮济医疗科技有限公司 Silver-containing fluorhydroxyapatite coating, and preparation method and application of coating
WO2017017167A1 (en) * 2015-07-28 2017-02-02 Ceramtec Gmbh Metallic and/or ceramic components with at least one osseointegrative and osteoinductive surface (multi)layer structure
DE102015115878B4 (en) * 2015-09-21 2018-03-29 Aap Implantate Ag A method of treating a metallic surface and bodies having a treated metallic surface
WO2017059296A1 (en) * 2015-10-02 2017-04-06 Conmed Corporation Regulating degradation of surgical implants
US10064273B2 (en) 2015-10-20 2018-08-28 MR Label Company Antimicrobial copper sheet overlays and related methods for making and using
WO2017132234A2 (en) * 2016-01-25 2017-08-03 Smith & Nephew, Inc. Orthopaedic implant
CN109152646B (en) * 2016-02-29 2021-01-26 美敦力索发摩尔丹耐克有限公司 Antibacterial device for implantation in vivo
CN109069188B (en) * 2016-02-29 2021-08-03 美敦力索发摩尔丹耐克有限公司 Set screw for an antibacterial body implant device
TR201614287A1 (en) * 2016-10-11 2018-04-24 Asghari Sana Farzin THE USE OF ANTIBACTERIAL NANOHYDROXYAPATITE NANOCOMPOSITE WITH ANTIBIOTICS
CN106492271B (en) * 2016-12-13 2019-11-01 温州医科大学附属口腔医院 The preparation of the antibacterial rush difunctional Guided Bone Regeneration Absorbable membrane of synosteosis
AU2017376835A1 (en) * 2016-12-16 2019-08-01 Field Orthopaedics Pty Ltd A medical implant and a method of coating a medical implant
US10537658B2 (en) 2017-03-28 2020-01-21 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline gallium-containing hydroxyapatite coating and methods for making the same
US10537661B2 (en) 2017-03-28 2020-01-21 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline calcium phosphate coating and methods for making the same
AU2018321578A1 (en) * 2017-08-24 2020-03-05 Boulos & Cooper Pharmaceuticals Pty Ltd Antimicrobial coating
WO2019071245A1 (en) 2017-10-06 2019-04-11 Foundry Therapeutics, Inc. Implantable depots for controlled release of analgesics to treat postoperative pain associated with orthopedic surgery, and associated devices, systems, and methods
CN108030960B (en) * 2017-12-22 2021-04-13 重庆医科大学附属永川医院 Implant material for promoting bone wound healing and preparation method thereof
AU2019214408B2 (en) * 2018-02-02 2023-02-02 Evonik Operations Gmbh Functionally graded polymer knee implant for enhanced fixation, wear resistance, and mechanical properties and the fabrication thereof
CN108379669B (en) * 2018-02-06 2021-04-30 中国科学院金属研究所 Medical catheter with copper-containing coating and preparation method thereof
CN108339160B (en) * 2018-02-06 2021-07-02 中国科学院金属研究所 Degradable magnesium alloy cardiovascular stent with copper-containing coating and preparation method thereof
ES2776887T3 (en) 2018-02-12 2020-08-03 Helmholtz Zentrum Geesthacht Method of producing a metal implant
RU2699093C1 (en) * 2018-11-01 2019-09-03 Федеральное государственное бюджетное учреждение науки Институт высокотемпературной электрохимии Уральского отделения Российской Академии наук Method of producing osteoplastic ceramic material based on calcium phosphate
US20200405908A1 (en) * 2019-06-28 2020-12-31 DePuy Synthes Products, Inc. Ion incorporated plasma sprayed hydroxyapatite coatings and method of making the same
AU2020310168A1 (en) * 2019-07-10 2022-03-03 David KEETON Medical device solutions for treating dental disease and methods for the treatment of dental disease
US11638776B1 (en) * 2019-10-07 2023-05-02 Smith & Nephew, Inc. Medical devices and methods for forming medical devices having a porous structure
KR20220115587A (en) * 2019-12-12 2022-08-17 네럼보 인코포레이티드 Functionalized textile compositions and articles
WO2021117051A1 (en) * 2019-12-14 2021-06-17 Meril Healthcare Pvt. Ltd Dual coating on medical implants
US20230080504A1 (en) * 2020-01-16 2023-03-16 The Johns Hopkins University Composite materials and embolization methods
US11730862B2 (en) * 2020-05-08 2023-08-22 DePuy Synthes Products, Inc. Identifier-based application of therapeutic coatings to medical implant devices
CN112603603A (en) * 2021-01-29 2021-04-06 郑州大学第一附属医院 Personalized prosthesis with antibacterial and bone promoting effects and its preparation method
CN114366849B (en) * 2021-12-07 2022-11-22 中山大学 Bone repair material and preparation method and application thereof
CN115569239A (en) * 2022-09-16 2023-01-06 张皓轩 Preparation method of vancomycin-carrying material
CN116036385B (en) * 2023-03-31 2023-07-04 艾柯医疗器械(北京)股份有限公司 Self-expanding braided implant, preparation method thereof and blood flow guiding system comprising same

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723038A (en) * 1995-02-10 1998-03-03 Jurgen Hofinger Process for producing a gradient coating made of calcium phosphate phases and metal oxide phase on metallic implants
WO2000023124A1 (en) * 1998-10-22 2000-04-27 Edwards Lifesciences Corporation Multi-functional coatings for medical devices
WO2002018003A1 (en) * 2000-08-30 2002-03-07 Biocoat Incorporated Bi-laminar, hyaluronan coatings with silver-based anti-microbial properties
WO2003070288A2 (en) * 2001-10-12 2003-08-28 Inframat Corporation Coated implants and methods of coating implants
US20040153165A1 (en) * 2003-01-31 2004-08-05 Depuy Products, Inc. Biological agent-containing ceramic coating and method
DE102004011293A1 (en) * 2004-03-09 2005-09-22 Aesculap Ag & Co. Kg Medical products for internal or external (e.g. wound enclosure) applications have polyhexamethylene biguanide (PHMB) as a non-specific antimicrobial component in the surface zone
US20060161256A1 (en) * 2002-09-17 2006-07-20 Gunter Ziegler Anti-infectious, biocompatible titanium coating for implants, and method for the production thereof
US20070198040A1 (en) * 2006-02-08 2007-08-23 Tyrx Pharma Inc. Temporarily Stiffened Mesh Prostheses
US20070287027A1 (en) * 2006-06-07 2007-12-13 Medicinelodge, Inc. Laser based metal deposition (lbmd) of antimicrobials to implant surfaces
WO2007144667A2 (en) * 2006-06-12 2007-12-21 Accentus Plc Metal implants

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127352A (en) * 1988-02-01 2000-10-03 Uribe; Jose R. Pharmaceutical compositions with analgesics containing codeine
US5009898A (en) * 1988-09-29 1991-04-23 Kabushiki Kaisha Sangi Antimicrobial hydroxyapatite powders and methods for preparing them
US5268174A (en) 1988-09-29 1993-12-07 Kabushiki Kaisha Sangi Antimicrobial hydroxyapatite powders containing hinokitiol, protamine or sorbic acid
IL96313A (en) 1989-11-14 1995-03-30 Sangi Kk Antibacterial ceramic material
JPH03161429A (en) * 1989-11-20 1991-07-11 Olympus Optical Co Ltd Sustained release material for drug
FR2673843B1 (en) 1991-03-14 1995-01-13 Centre Nat Rech Scient IMPLANTABLE, BIORESORBABLE PHARMACEUTICAL COMPOSITION BASED ON POLY (LACTIC ACID), INTENDED TO IMPLEMENT A LOCAL INTERNAL ANTIBOTHERAPY.
JP3051228B2 (en) 1991-10-31 2000-06-12 株式会社サンギ Antibacterial tricalcium phosphate
JPH05124919A (en) 1991-11-05 1993-05-21 Sangi Co Ltd Antibacterial ceramics
CA2187512C (en) 1995-02-10 2007-05-29 Dieter Scharnweber Process for producing a graduated coating of calcium phosphate phases and metallic oxide phases on metal implants
DE19608423A1 (en) 1996-03-05 1997-09-11 Merck Patent Gmbh Phased drug delivery implants
US6143948A (en) * 1996-05-10 2000-11-07 Isotis B.V. Device for incorporation and release of biologically active agents
JP3455382B2 (en) * 1996-11-22 2003-10-14 重雄 丸野 Implant material
SE9701647D0 (en) 1997-04-30 1997-04-30 Nobel Biocare Ab Calcium-phonsphate coated implant element
WO1999011202A1 (en) 1997-09-05 1999-03-11 Icet, Inc. Biomimetic calcium phosphate implant coatings and methods for making the same
ES2201571T3 (en) 1997-11-24 2004-03-16 Morphoplant Gmbh PROCEDURE FOR THE IMMOBILIZATION OF MEDIATING MOLECULES ON MATERIALS OF INORGANIC AND METALLIC IMPLANTS.
US6582715B1 (en) 1999-04-27 2003-06-24 Agion Technologies, Inc. Antimicrobial orthopedic implants
DK1196150T3 (en) * 1999-06-14 2005-11-21 Imp College Innovations Ltd Solvent-containing sol-gel-derived bioglass compositions
GB9924086D0 (en) 1999-10-12 1999-12-15 Maltin Christopher Fluid treatment apparatus
US6719987B2 (en) 2000-04-17 2004-04-13 Nucryst Pharmaceuticals Corp. Antimicrobial bioabsorbable materials
DE10029520A1 (en) * 2000-06-21 2002-01-17 Merck Patent Gmbh Coating for metallic implant materials
JP2004536621A (en) * 2001-01-30 2004-12-09 イソティス エス．エー． Method of applying a bioactive coating to a medical device
EP1539270A1 (en) 2002-09-18 2005-06-15 Medtronic Vascular, Inc. Controllable drug releasing gradient coatings for medical devices
US20060286140A1 (en) 2003-09-15 2006-12-21 Eric Wickstrom Implants with attached silylated therapeutic agents
JP4505578B2 (en) * 2004-05-20 2010-07-21 株式会社神戸製鋼所 Implant material and manufacturing method thereof
US8491936B2 (en) * 2005-03-16 2013-07-23 North Carolina State University Functionally graded biocompatible coating and coated implant
WO2007022211A2 (en) 2005-08-15 2007-02-22 New York University Zinc-releasing zinc-calcium phosphate dental coating
EP1764119A1 (en) 2005-09-09 2007-03-21 NOLabs AB Implants with improved osteointegration
DE102005051417A1 (en) 2005-10-27 2007-05-03 X-Fab Semiconductor Foundries Ag Simulation or layout method for vertical power transistors with variable channel width and variable gate-drain capacitance
US10029034B2 (en) * 2005-12-15 2018-07-24 CARDINAL HEALTH SWITZERLAND 515 GmbH Drug-eluting articles with improved drug release profiles
US8765178B2 (en) 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
JP5069888B2 (en) * 2006-09-19 2012-11-07 国立大学法人佐賀大学 Biological implant
CN102014975A (en) 2008-02-29 2011-04-13 史密夫和内修有限公司 Gradient coating for biomedical applications
CN105963781A (en) 2008-02-29 2016-09-28 史密夫和内修有限公司 Coating and coating method

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723038A (en) * 1995-02-10 1998-03-03 Jurgen Hofinger Process for producing a gradient coating made of calcium phosphate phases and metal oxide phase on metallic implants
WO2000023124A1 (en) * 1998-10-22 2000-04-27 Edwards Lifesciences Corporation Multi-functional coatings for medical devices
WO2002018003A1 (en) * 2000-08-30 2002-03-07 Biocoat Incorporated Bi-laminar, hyaluronan coatings with silver-based anti-microbial properties
WO2003070288A2 (en) * 2001-10-12 2003-08-28 Inframat Corporation Coated implants and methods of coating implants
US20060161256A1 (en) * 2002-09-17 2006-07-20 Gunter Ziegler Anti-infectious, biocompatible titanium coating for implants, and method for the production thereof
US20040153165A1 (en) * 2003-01-31 2004-08-05 Depuy Products, Inc. Biological agent-containing ceramic coating and method
DE102004011293A1 (en) * 2004-03-09 2005-09-22 Aesculap Ag & Co. Kg Medical products for internal or external (e.g. wound enclosure) applications have polyhexamethylene biguanide (PHMB) as a non-specific antimicrobial component in the surface zone
US20070198040A1 (en) * 2006-02-08 2007-08-23 Tyrx Pharma Inc. Temporarily Stiffened Mesh Prostheses
US20070287027A1 (en) * 2006-06-07 2007-12-13 Medicinelodge, Inc. Laser based metal deposition (lbmd) of antimicrobials to implant surfaces
WO2007144667A2 (en) * 2006-06-12 2007-12-21 Accentus Plc Metal implants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LING FENG Q ET AL: "Antibacterial effects of Ag-HAp thin films on alumina substrates", THIN SOLID FILMS, ELSEVIER, AMSTERDAM, NL, vol. 335, no. 1-2, 19 November 1998 (1998-11-19), pages 214 - 219, XP004153007, ISSN: 0040-6090, DOI: 10.1016/S0040-6090(98)00956-0 *

Also Published As

Publication number Publication date
US9011965B2 (en) 2015-04-21
JP2017060889A (en) 2017-03-30
EP2259805A4 (en) 2013-08-07
CN105688276A (en) 2016-06-22
EP2259805B1 (en) 2016-08-17
AU2009222165A1 (en) 2009-09-11
US20110014258A1 (en) 2011-01-20
EP2259805A2 (en) 2010-12-15
EP3159018A2 (en) 2017-04-26
CN102014975A (en) 2011-04-13
CA2716896C (en) 2016-08-09
EP3159018B1 (en) 2022-04-20
JP2011512957A (en) 2011-04-28
AU2015238865B2 (en) 2016-11-17
JP2015057126A (en) 2015-03-26
AU2009222165B2 (en) 2015-07-09
JP6596200B2 (en) 2019-10-23
WO2009111300A2 (en) 2009-09-11
ES2603961T3 (en) 2017-03-02
JP2019150648A (en) 2019-09-12
AU2015238865A1 (en) 2015-10-29
WO2009111300A3 (en) 2009-12-10
CA2716896A1 (en) 2009-09-11

Similar Documents

Publication Publication Date Title
EP3159018A3 (en) Gradient coating for biomedical applications
EP3095463A3 (en) Methods for treating progressive multiple sclerosis
ES2578527T3 (en) Coated items
WO2008042748A3 (en) Polyelectrolyte media for bioactive agent delivery
EP2261186A3 (en) Low maintenance coating technology
EP2147957A4 (en) Hydrophilic coating composition and hydrophilic member using the same
EP3254678A3 (en) Multifunctional zwitterionic polymer conjugates
EP3409214A3 (en) Self-retaining sutures for surgical procedures
EP2591804A3 (en) Polymer nanoparticles coated by magnetic metal oxide and uses thereof
WO2008151022A3 (en) Nucleic acid nanoparticles and uses therefor
EP3320911A3 (en) Activin-actrii antagonists and uses for increasing red blood cell levels
EP1825948A3 (en) Nozzle for laser net shape manufacturing
EP2452709A3 (en) Inserter assembly
EP2730576A3 (en) Anti-infective compounds
WO2008140594A3 (en) Peptide nanoparticles and uses therefor
DK1957130T3 (en) Hydrophilic coating comprising a polyelectrolyte
WO2011137323A3 (en) Nonwoven having durable hydrophilic coating
EP2338551A3 (en) A device and a system for delivery of biological material
EP2103718A4 (en) Method for coating ceramic film on metal, electrolysis solution for use in the method, and ceramic film and metal material
WO2006123336A3 (en) Low friction coatings for use in dental and medical devices
EP2236491A3 (en) Crystalline form of tigecycline and processes for preparation thereof
WO2007028607A3 (en) Antimicrobial medical product, method for the production thereof and use thereof
EP2362224A3 (en) Blood group antigens of different types for diagnostic and therapeutic applications
EP2157112A3 (en) Alkylated polyalkylene polyamines and uses thereof
WO2007089592A3 (en) Implantable medical device coated with bioactive agent

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AC Divisional application: reference to earlier application

Ref document number: 2259805

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

RIC1 Information provided on ipc code assigned before grant

Ipc: A61L 27/54 20060101ALI20170405BHEP

Ipc: A61L 27/30 20060101AFI20170405BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20171110

RBV Designated contracting states (corrected)

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20180827

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20211118

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AC Divisional application: reference to earlier application

Ref document number: 2259805

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602009064406

Country of ref document: DE

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1484675

Country of ref document: AT

Kind code of ref document: T

Effective date: 20220515

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20220420

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1484675

Country of ref document: AT

Kind code of ref document: T

Effective date: 20220420

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220420

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220420

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220822

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220720

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220420

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220420

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220721

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220420

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220420

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220720

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220420

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220420

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220420

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220820

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602009064406

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220420

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220420

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220420

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220420

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220420

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20230123

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230110

Year of fee payment: 15

Ref country code: CH

Payment date: 20230307

Year of fee payment: 15

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220420

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20230105

Year of fee payment: 15

Ref country code: DE

Payment date: 20221230

Year of fee payment: 15

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230526

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220420

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20230228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230227

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220420

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230227

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230228